Sign in
4

Changes in Ownership

Cocrystal Pharma, Inc. Filed Acc 0001415889-15-003251

Options or other derivatives

  • CHIEF EXECUTIVE OFFICER acquired 16,000,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Meckler Jeffrey A CHIEF EXECUTIVE OFFICER 2015-10-01 Grant or award · Stock Option (Right to Buy) +16,000,000 16,000,000 D
Loading xslF345X03/form4-10022015_041009.xml…